GB202018400D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB202018400D0
GB202018400D0 GBGB2018400.8A GB202018400A GB202018400D0 GB 202018400 D0 GB202018400 D0 GB 202018400D0 GB 202018400 A GB202018400 A GB 202018400A GB 202018400 D0 GB202018400 D0 GB 202018400D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2018400.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Healx Ltd
Original Assignee
Healx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healx Ltd filed Critical Healx Ltd
Priority to GBGB2018400.8A priority Critical patent/GB202018400D0/en
Publication of GB202018400D0 publication Critical patent/GB202018400D0/en
Priority to PCT/GB2021/053020 priority patent/WO2022106851A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2018400.8A 2020-11-23 2020-11-23 Treatment Ceased GB202018400D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2018400.8A GB202018400D0 (en) 2020-11-23 2020-11-23 Treatment
PCT/GB2021/053020 WO2022106851A1 (fr) 2020-11-23 2021-11-23 Mebendazole pour une utilisation dans le traitement de la polykystose rénale autosomique dominante ou de la polykystose rénale autosomique récessive

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2018400.8A GB202018400D0 (en) 2020-11-23 2020-11-23 Treatment

Publications (1)

Publication Number Publication Date
GB202018400D0 true GB202018400D0 (en) 2021-01-06

Family

ID=74046975

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2018400.8A Ceased GB202018400D0 (en) 2020-11-23 2020-11-23 Treatment

Country Status (2)

Country Link
GB (1) GB202018400D0 (fr)
WO (1) WO2022106851A1 (fr)

Also Published As

Publication number Publication date
WO2022106851A1 (fr) 2022-05-27

Similar Documents

Publication Publication Date Title
GB202108224D0 (en) Treatment
GB202116743D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202006236D0 (en) New treatment
IL312981A (en) care
GB202114373D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202101875D0 (en) Treatment
GB202101897D0 (en) Treatment
GB202101210D0 (en) Treatment
GB202101211D0 (en) Treatment
GB202101212D0 (en) Treatment
GB202101213D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)